Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-31

FDA Approved: ROPINIROLE — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic version of Ropinirole from Solco Healthcare US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

SUPPL AP for ROPINIROLE (ROPINIROLE)